Indian pharmaceutical stocks showed a mixed trend on May 13 2026 during the early morning trading session. The BSE Healthcare index remained nearly flat, rising marginally by 0.04% to 46,087.93. Meanwhile, the broader market continued to trade in negative territory with the Nifty 50 declining 0.35% to 23,298.75 and the S&P BSE Sensex falling 0.41% to 74,252.54 as of around 9:54 AM.
Top Gainers in Pharma Sector
- Wockhardt emerged as one of the top performers, rising 1.97% on BSE to ₹1,601.90 and 1.61% on NSE to ₹1,595.70.
- Biocon gained 1.38% on BSE to ₹407.70 and 1.27% on NSE.
- Cipla advanced 0.97–1.05%.
- Sudeep Pharma Ltd. rose 1.45% on NSE.
Other stocks that posted gains included Ajanta Pharma, Panacea Biotech, Indoco Remedies, Strides Pharma Science, Natco Pharma, Alembic Pharma, and Aurobindo Pharma.
Major Losers in Pharma Sector
- Orchid Pharma witnessed the biggest decline among the listed stocks, falling 0.95% on BSE to ₹701.05 and 1.79% on NSE.
- J.B. Chemicals was down 0.69–0.94%.
- Lupin declined 0.68–0.76%.
- Torrent Pharma slipped 0.57–0.92%.
Stocks such as Sun Pharma, Zydus Lifesciences, and Glenmark Pharma also traded with mild losses in the early session.
Most other major pharma companies including Divis Laboratories, Dr. Reddy’s Lab, IPCA Labs, Mankind Pharma, and Dr. Reddy’s Laboratories saw limited movement with small positive changes.
Note: All prices and percentage changes are based on data as of 9:48 AM on BSE and 9:49 AM on NSE on May 13 2026. Market prices are volatile and continue to change rapidly. This is for informational purposes only and does not constitute investment advice. For the latest live prices, please check the official NSE and BSE websites.